Ann K. Cashion | |
---|---|
Director of the National Institute of Nursing Research | |
Acting | |
In office September 2018 – September 2019 | |
Preceded by | Patricia A. Grady |
Succeeded by | Lawrence A. Tabak (acting) |
Personal details | |
Alma mater | University of North Carolina at Chapel Hill University of Arkansas for Medical Sciences University of Tennessee Health Science Center |
Ann King Cashion is an American nurse scientist specialized in genetic markers that predict clinical outcomes. She is a professor emerita in the department of health promotion/disease prevention at the University of Tennessee Health Science Center. Cashion was the acting director of the National Institute of Nursing Research from 2018 to 2019.
Life
Cashion completed a B.S.N. in Nursing at the University of North Carolina at Chapel Hill in 1978.[1] She earned a MNSc in Nursing/Adult at the University of Arkansas for Medical Sciences.[1] Cashion practiced as a critical care nurse and clinical nurse specialist for nearly two decades in Little Rock, Arkansas.[2] She completed a Ph.D. in Nursing at the University of Tennessee Health Science Center in 1998.[1] Her dissertation was titled Measurement of Autonomic Function in Renal Disease and Diabetes. Kay F. Engelhardt was her doctoral advisor.[3] In 2000, Cashion completed postdoctoral research in molecular genetics at the National Institute of Nursing Research and Georgetown University.[1]
In 2000, Cashion joined the faculty of the College of Nursing at the University of Tennessee Health Science Center (UTHSC).[4] From 2008 to 2013, she was a professor in the college of nursing.[1] Cashion chaired the department of acute and chronic care from 2005 to 2012.[4][1] In 2006, she was elected a fellow of the American Academy of Nursing.[1] During her tenure there, Cashion researched social, environmental and genetic markers to predict patient outcomes and guide therapies in solid organ transplant recipients.[4] She researched the factors leading to post-transplant weight gain.[2] Her expertise is in genetic markers that predict clinical outcomes, in particular the genetic/genomic and environmental components associated with outcomes of organ transplantation.[2] Cashion combined genomic technology (microarrays) and behavioral questionnaires to investigate the gene-environment interactions leading to obesity in recipients of kidney transplantations during the first year after transplant.[2] She expands her work as the lead investigator of NINR’s Genomic and Clinical Biomarkers Lab, where she uses the NIH-Symptom Science Model to identify biomarkers to predict "at-risk" populations and guide therapeutic management for multiple health outcomes.[2] Cashion served as president of the International Society of Nurses in Genetics.[2]
Cashion joined the National Institute of Nursing Research (NINR) in 2011 as a senior advisor to then-NINR director Patricia A. Grady.[4] She served as acting scientific director before being appointed permanently in November 2013.[4][5] Cashion was named NINR acting deputy director in January 2018.[2] Cashion was the acting NINR director from September 2018 until September 30, 2019.[4] Lawrence A. Tabak succeeded Cashion as the acting NINR director.[6]
On July 1, 2020, Cashion rejoined the UTHSC as a professor in the college of nursing.[1] As of 2022, she is a professor emerita in the department of health promotion/disease prevention.[1]
References
- 1 2 3 4 5 6 7 8 9 "Ann K Cashion, PhD, RN, FAAN". University of Tennessee Health Science Center. Retrieved 2022-10-09.
- 1 2 3 4 5 6 7 "DIR Scientific Director: Dr. Ann Cashion". National Institutes of Health. Archived from the original on 2018-07-22. Retrieved 2022-10-09. This article incorporates text from this source, which is in the public domain.
- ↑ Cashion, Ann King (1998-06-01). Measurement of Autonomic Function in Renal Disease and Diabetes (Doctor of Philosophy thesis). Memphis, TN: University of Tennessee Health Science Center. doi:10.21007/etd.cghs.1998.0044.
- 1 2 3 4 5 6 Kriebel, Jo-Ann (2019-10-18). "Cashion Retires as NINR Acting Director". NIH Record. Retrieved 2022-10-09. This article incorporates text from this source, which is in the public domain.
- ↑ "Dr. Ann Cashion Named Scientific Director, Division of Intramural Research | National Institute of Nursing Research". www.ninr.nih.gov. Retrieved 2022-10-09. This article incorporates text from this source, which is in the public domain.
- ↑ "NINR Acting Director and Scientific Director Dr. Ann Cashion to Retire". www.ninr.nih.gov. August 20, 2019. Retrieved 2022-10-10.